A Pharmacokinetic Evaluation of Etonogestrel (ENG) Implant and Antiretroviral Therapy
This study has been completed.
University of Pittsburgh
Information provided by (Responsible Party):
Catherine Chappell, University of Pittsburgh
First received: March 6, 2014
Last updated: September 13, 2017
Last verified: September 2017
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||March 2016|
|Primary Completion Date:||March 2016 (Final data collection date for primary outcome measure)|
Chappell CA, Lamorde M, Nakalema S, Chen BA, Mackline H, Riddler SA, Cohn SE, Darin KM, Achilles SL, Scarsi KK. Efavirenz decreases etonogestrel exposure: a pharmacokinetic evaluation of implantable contraception with antiretroviral therapy. AIDS. 2017 Sep 10;31(14):1965-1972. doi: 10.1097/QAD.0000000000001591.